Is yo-yo dieting bad for you? Weight that swings up and down tracks worse health
Across 23 cohort studies and 441,199 people, large weight fluctuation was linked to a 41% higher risk of death. Whether the cycling itself does harm, or reflects who cycles, the data cannot fully separate.
| Group | Value (% higher risk) |
|---|---|
| Coronary event | 64 |
| Cardiovascular event | 85 |
| Heart attack | 117 |
| Death | 124 |
| Stroke | 136 |
The honest answer is a qualified one: the pattern is worrying, but the cause is unsettled. People whose weight swings up and down repeatedly have measurably worse health outcomes, on average, than people whose weight stays stable — yet the studies cannot fully prove the cycling itself is the culprit rather than a marker of who tends to cycle [s1] [s2].
What the pooled data show
A 2019 systematic review combined 25 publications from 23 cohort studies, covering 441,199 participants, to test whether body-weight fluctuation predicts death and cardiovascular disease [s1]. It did. Greater weight variability was associated with a 41% higher risk of all-cause mortality (relative risk 1.41; 95% CI 1.27–1.57), a 36% higher risk of cardiovascular death (RR 1.36; 1.22–1.52), a 49% higher risk of developing cardiovascular disease (RR 1.49; 1.26–1.76) and a 35% higher risk of hypertension (RR 1.35; 1.14–1.61) [s1].
One result cuts against a simple "instability is toxic" story: weight fluctuation was not associated with cancer mortality (RR 1.01; 0.90–1.13) [s1]. If swinging weight directly damaged the body across the board, you might expect a cancer signal too; its absence hints that at least part of the association reflects cardiovascular-specific mechanisms, confounding, or both [s1]. The review also noted its own limits: it drew on observational cohorts of differing quality, and it found signs of publication bias for the all-cause mortality estimate specifically, which argues for reading even the headline 41% figure as a signal to investigate rather than a settled effect size [s1].
A closer look inside one trial
The largest single analysis comes from the Treating to New Targets trial, which followed 9,509 people with existing coronary disease and tracked how much each person's weight bounced between visits [s2]. After adjusting for standard risk factors, baseline weight and overall weight change, each one-standard-deviation increase in weight variability was associated with a higher risk of any coronary event (hazard ratio 1.04; 95% CI 1.01–1.07), any cardiovascular event (HR 1.04; 1.02–1.07) and death (HR 1.09; 1.07–1.12) [s2].
Framed by the extremes, the gap is large. Compared with the fifth of patients whose weight was most stable, the fifth whose weight varied most had a 64% higher risk of a coronary event, an 85% higher risk of a cardiovascular event, a 124% higher risk of death, a 117% higher risk of heart attack and a 136% higher risk of stroke [s2]. The associations held independent of traditional risk factors [s2].
Why this is not a licence to stay heavy
The crucial caveat is the direction of causation. These are observational findings, and weight that lurches downward is often a sign of illness — undiagnosed cancer, heart failure, frailty — which itself raises mortality [s1] [s2]. Studies like these cannot cleanly separate deliberate diet-and-regain cycles from involuntary weight loss driven by disease, and neither paper claims to have proven that intentional dieting followed by regain is harmful [s1] [s2].
What the evidence certainly does not support is the opposite over-reading — that because regain is common and fluctuation looks risky, losing weight is not worth attempting. Deliberate weight loss improves blood pressure, glucose and other risk markers, and the fluctuation signal is a reason to prioritise keeping weight off, not a reason to avoid losing it in the first place [s2].
There is also a measurement subtlety. "Variability" in these studies is a statistical summary of how much weight moved between visits, not a clean record of intentional diets; someone with unstable weight from illness, medication or life upheaval is scored the same as a serial dieter [s1] [s2]. That is precisely why the association, however consistent, stops short of proving that the act of cycling is what does the damage.
The practical reading: the goal the data reward is stability at a lower weight, not a cycle of aggressive loss and rebound. That points back to the same conclusion as the regain literature — maintenance deserves as much planning as the diet itself, because a weight you can hold is worth more than a lower number you cannot. And for anyone whose weight is falling without trying, that is a reason to see a doctor, not to celebrate [s1] [s2].
This article is informational and is not medical advice.
Sources
- Body-Weight Fluctuation Was Associated With Increased Risk for Cardiovascular Disease, All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-Analysis — Frontiers in Endocrinology, 2019-11-07
- Body-Weight Fluctuations and Outcomes in Coronary Disease — New England Journal of Medicine, 2017-04-05
Sources
- Body-Weight Fluctuation Was Associated With Increased Risk for Cardiovascular Disease, All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-Analysis — Frontiers in Endocrinology , November 7, 2019
- Body-Weight Fluctuations and Outcomes in Coronary Disease — New England Journal of Medicine , April 5, 2017
More on
Does the paleo diet work? The trials say yes, then not so much
Randomised trials show a Palaeolithic diet trims weight and risk markers in the short term. A two-year trial found the early edge over an ordinary healthy diet had mostly faded — and that people struggled to stick to it.
Higher pre-pregnancy weight tracks with offspring heart disease decades on
In 2.5 million Swedish births followed to adulthood, mothers' early-pregnancy obesity was linked to a stepwise rise in offspring cardiovascular disease, though sibling analyses temper the size.
Obesity from MC4R mutations came with lower cholesterol, not higher
Carriers of loss-of-function MC4R mutations had lower LDL and triglycerides than UK Biobank controls of similar adiposity, and lower cardiovascular risk. The brain sets body weight and lipids separately.
Does apple cider vinegar help you lose weight? What the trials show
A 2025 meta-analysis of 10 trials found small, short-term reductions in weight and BMI — but the studies were heterogeneous, and the viral single trial that fuelled the hype is one small study, not a settled result.